相关实验视频
Updated: Jul 18, 2026

08:45
Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring
Published on: November 13, 2012
13.7K
在斯坦福癌症研究所的癌症幸存者
Stephanie M Smith1, Natasha Steele2, Jennifer Kim3
1Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, USA.
Journal of cancer survivorship : research and practice
|January 6, 2024
概括
斯坦福大学 斯坦福大学 斯坦福大学
科学领域:
- 在瘤学瘤学.
- 癌症的生存率 癌症的生存率
- 公共卫生 公共卫生
背景情况:
- 斯坦福癌症幸存者计划满足癌症患者及其家属的综合需求.
- 它的重点是改善患者和护理人员的体验和癌症连续性的结果.
研究的目的:
- 概述斯坦福癌症幸存者计划的使命,结构和关键举措.
- 为癌症幸存者强调研究,临床护理,教育和社区参与方面的进步.
主要方法:
- 该计划整合了临床护理,专业教育,以患者为导向的研究和社区参与.
- 关键领域包括青少年和年轻人 (AYAs),心理健康,初级保健整合和研究生医学教育.
- 临床护理模式包括嵌入式诊所,新型专科服务和基于初级保健的诊所.
主要成果:
- 教育举措包括在线课程,教科书,讲座和实习生轮换.
- 面向患者的活动包括网络研讨会和播客,以传播信息.
- 研究探讨了cofertility,AYA沟通,为生活质量提供数字干预以及社区伙伴关系.
结论:
- 斯坦福大学的癌症生存计划为研究,培训和临床护理提供了一个全面的平台.
- 该计划致力于通过创新的方法提高与癌症相处和超越癌症的个体的获得和改善护理.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

